MUNICH, April 17 (Reuters) - German medical packaging

maker Gerresheimer has rejected a takeover bid from

its U.S. rival Silgan ( SLGN ), three sources familiar with the

situation told Reuters.

There are no longer any talks between the two companies,

according to the sources.

One source said that Gerresheimer wants to focus for now on

resolving its accounting problems and selling its U.S.

subsidiary Centor.

Reuters reported in March that Silgan ( SLGN ) had signalled an

interest in taking over Gerresheimer with a non-binding offer of

41 euros ($48.31) per share, more than double the current share

price.

A Gerresheimer spokesperson said the company does not

comment on market rumours. Silgan ( SLGN ) did not respond to a request

for comment.

($1 = 0.8488 euros)